Welcome : Guest

ProQR Therapeutics N.V. (The Netherlands) - Facts, Figures and Analytical Insights


This report presents quick facts about ProQR Therapeutics N.V., which is principally a Biopharmaceutical Company. Illustrated with 12 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65202
Price: $600
Company Type: Public
Pages: 14
Date: January 2017
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cystic Fibrosis (CF)......3
Table 1: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......3
Table 2: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......4
Table 3: Drugs for Treatment of Cystic Fibrosis Market Worldwide (2015) in US$ Million......5
Molecular Cystic Fibrosis (CF) Testing......6
Table 4: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......6
Molecular Diagnostic Genetics Laboratories......7
Table 5: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......7
Table 6: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......8
Retinitis Pigmentosa......9
Table 7: Retinitis Pigmentosa Market by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Autosomal Dominant Retinitis Pigmentosa, Autosomal Recessive Retinitis Pigmentosa, Bardet- Biedl Syndrome, Isolated and Unknown Retinitis Pigmentosa, Leber Congenital Amaurosis, Usher Syndrome, X Linked Retinitis Pigmentosa, and Others......9
Alzheimer Disease Therapeutics......10
Table 8: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......10
Generic Pharmaceuticals......11
Table 9: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......11
Table 10: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......12
Table 11: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......13
Alzheimer's Disease......14
Table 12: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......14